BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6130585)

  • 21. [Prenatal diagnosis of incurable familial metabolic diseases. Prenatal diagnosis of disorders of lipid metabolism].
    Harzer K
    Med Welt; 1979; 30(48):1810-6. PubMed ID: 42836
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lysosome enzyme pseudodeficiency].
    Bronner P; Rodier G; Cohen E; Derouiche F; Boulay C; Courtois S
    Rev Neurol (Paris); 2000 Nov; 156(11):1005-12. PubMed ID: 11119053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amniotic tissue transplantation: clinical and biochemical evaluations for some lysosomal storage diseases.
    Sakuragawa N; Yoshikawa H; Sasaki M
    Brain Dev; 1992 Jan; 14(1):7-11. PubMed ID: 1590532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-hexosaminidase isozymes and replacement therapy in Gm2 gangliosidosis.
    Rattazzi MC
    Isozymes Curr Top Biol Med Res; 1983; 11():65-81. PubMed ID: 6227586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipid histochemical studies of lysosomal lipid metabolism diseases].
    Dietzmann K; Mohnike D
    Acta Histochem Suppl; 1984; 30():211-3. PubMed ID: 6201955
    [No Abstract]   [Full Text] [Related]  

  • 26. Metachromatic leukodystrophy: an overview of current and prospective treatments.
    Biffi A; Lucchini G; Rovelli A; Sessa M
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S2-6. PubMed ID: 18978739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal liver transplantation in immunodeficiencies and inborn errors of metabolism.
    Touraine JL; Roncarolo MG; Marseglia GL; Souillet G; Bétend B; Bétuel H; Touraine F; Royo C; Philippe N; François R
    Prog Clin Biol Res; 1985; 193():299-313. PubMed ID: 3937157
    [No Abstract]   [Full Text] [Related]  

  • 28. Sphingolipidoses.
    Sandhoff K
    J Clin Pathol Suppl (R Coll Pathol); 1974; 8():94-105. PubMed ID: 4157247
    [No Abstract]   [Full Text] [Related]  

  • 29. Electron microscopy: a method for the diagnosis of inherited metabolic storage diseases. Electron microscopy in diagnosis.
    Spycher MA
    Pathol Res Pract; 1980 May; 167(1):118-35. PubMed ID: 6779268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients.
    Müller I; Kustermann-Kuhn B; Holzwarth C; Isensee G; Vaegler M; Harzer K; Krägeloh-Mann I; Handgretinger R; Bruchelt G
    Exp Hematol; 2006 Oct; 34(10):1413-9. PubMed ID: 16982334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rare inborn errors of lysosomal metabolism, implications for pediatric research (author's transl)].
    Wiesmann N; Herschkowitz N
    Schweiz Rundsch Med Prax; 1975 Sep; 64(35):114-9. PubMed ID: 2909
    [No Abstract]   [Full Text] [Related]  

  • 32. Tay-Sachs carrier detection.
    Wappner RS
    J Indiana State Med Assoc; 1982 Apr; 75(4):251-4. PubMed ID: 6211494
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of properties of the enzymes involved in metachromatic leukodystrophy and in Tay-Sachs disease.
    Jatzkewitz H
    Biochem Soc Symp; 1972; (35):141-50. PubMed ID: 4614800
    [No Abstract]   [Full Text] [Related]  

  • 34. Control and therapy of lipid storage diseases: present status and future strategies.
    Brady RO
    Ala J Med Sci; 1982 Apr; 19(2):161-4. PubMed ID: 7103002
    [No Abstract]   [Full Text] [Related]  

  • 35. Enzymatic abnormalities in diseases of sphingolipid metabolism.
    Brady RO
    Clin Chem; 1967 Jul; 13(7):565-77. PubMed ID: 5006481
    [No Abstract]   [Full Text] [Related]  

  • 36. Brain lysosomal enzymes in generalized gangliosidosis and metachromatic leukodystrophy.
    Den Tandt WR; Hooghwinkel GJ
    Acta Neurol (Napoli); 1980 Feb; 2(1):10-4. PubMed ID: 6156575
    [No Abstract]   [Full Text] [Related]  

  • 37. Late-onset Tay-Sachs disease.
    Neudorfer O; Kolodny EH
    Isr Med Assoc J; 2004 Feb; 6(2):107-11. PubMed ID: 14986470
    [No Abstract]   [Full Text] [Related]  

  • 38. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
    Fabrega S; Lehn P
    J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gaucher and Fabry diseases: from understanding pathophysiology to rational therapies.
    Brady RO
    Acta Paediatr Suppl; 2003 Dec; 92(443):19-24. PubMed ID: 14989461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and therapeutic applications of sphingolipid hydrolyzing enzymes.
    Brady RO
    Curr Top Cell Regul; 1985; 26():39-50. PubMed ID: 3935381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.